These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32438377)

  • 1. Exploring medicinal use of cannabis in a time of policy change in New Zealand.
    Rychert M; Wilkins C; Parker K; Graydon-Guy T
    N Z Med J; 2020 May; 133(1515):54-69. PubMed ID: 32438377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of medicinal cannabis users' willingness to utilise a new prescription Medicinal Cannabis Scheme in New Zealand.
    Rychert M; Parker K; Wilkins C; Graydon-Guy T
    N Z Med J; 2021 Apr; 134(1534):66-75. PubMed ID: 33927439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cannabis experiment.
    Cressey D
    Nature; 2015 Aug; 524(7565):280-3. PubMed ID: 26295084
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
    Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
    Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users.
    Pledger M; Martin G; Cumming J
    N Z Med J; 2016 Apr; 129(1433):25-36. PubMed ID: 27349158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Doctor's Case for Medical Marijuana.
    American Society of Consultant Pharmacists
    Consult Pharm; 2016 Jul; 31(7):354-5. PubMed ID: 27412310
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16).
    Lintzeris N; Driels J; Elias N; Arnold JC; McGregor IS; Allsop DJ
    Med J Aust; 2018 Aug; 209(5):211-216. PubMed ID: 30092752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes towards and use of cannabis in New Zealand patients with inflammatory bowel disease: an exploratory study.
    Appleton K; Whittaker E; Cohen Z; Rhodes HM; Dunn C; Murphy S; Gaastra M; Galletly A; Dougherty S; Haren A; Sukumaran N; Aluzaite K; Dockerty JD; Turner RM; Schultz M
    N Z Med J; 2021 Feb; 134(1530):38-47. PubMed ID: 33651776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes towards cannabis and cannabis law change in a New Zealand birth cohort.
    Boden JM; Cleland L; Dhakal B; Horwood LJ
    N Z Med J; 2020 May; 133(1515):79-88. PubMed ID: 32438379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.
    Walsh Z; Callaway R; Belle-Isle L; Capler R; Kay R; Lucas P; Holtzman S
    Int J Drug Policy; 2013 Nov; 24(6):511-6. PubMed ID: 24095000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients.
    Lucas P; Walsh Z
    Int J Drug Policy; 2017 Apr; 42():30-35. PubMed ID: 28189912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabis - medicinal use].
    Erbe B
    Dtsch Med Wochenschr; 2014 Jan; 139(3):74-5. PubMed ID: 24555193
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical Cannabis Users' Comparisons between Medical Cannabis and Mainstream Medicine.
    Kruger DJ; Kruger JS
    J Psychoactive Drugs; 2019; 51(1):31-36. PubMed ID: 30616501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation.
    Luckett T; Phillips J; Lintzeris N; Allsop D; Lee J; Solowij N; Martin J; Lam L; Aggarwal R; McCaffrey N; Currow D; Chye R; Lovell M; McGregor I; Agar M
    Intern Med J; 2016 Nov; 46(11):1269-1275. PubMed ID: 27530738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users.
    Pearce DD; Mitsouras K; Irizarry KJ
    J Altern Complement Med; 2014 Oct; 20(10):787-91. PubMed ID: 25191852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22).
    Mills L; Arnold JC; Suraev A; Abelev SV; Zhou C; Arkell TR; McGregor IS; Lintzeris N
    Harm Reduct J; 2024 May; 21(1):104. PubMed ID: 38807133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use.
    Suraev AS; Todd L; Bowen MT; Allsop DJ; McGregor IS; Ireland C; Lintzeris N
    Epilepsy Behav; 2017 May; 70(Pt B):334-340. PubMed ID: 28238865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
    Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
    Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
    Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
    Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.
    Bonn-Miller MO; Boden MT; Bucossi MM; Babson KA
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):23-30. PubMed ID: 24205805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.